3D-PharmXchange and Antleron Join Forces for the Living Factory 4.0 Project
3D-PharmXchange is proud to announce its collaboration with Antleron in the Living Factory 4.0 project. Antleron is a Leuven-based R&D company that develops custom bioprocess solutions for cell & gene therapy applications,…
Ronald van der Geest attending Life Sciences & Health ROMs Day
Empowering Dutch Biotech: Navigating Innovation and Market Success with the Dutch Regional Development Agencies on November 21, 2024 Ronald van der Geest, partner at 3D-PharmXchange, has been invited to attend…
Patient-Driven Drug Development: Does Patient Involvement Truly Improve the Success Rates of New Treatments?
In recent years, the biotechnology industry has seen a transformative shift towards patient-driven drug development. At 3D-PharmXchange, we have experienced firsthand the impact that patient involvement can have on the…
Inez de Greef elected to the NAE
Inez de Greef elected as fellow of the Netherlands Academy of Engineering We are thrilled to announce that Inez de Greef, CEO of Treeway and co-founder and Managing Partner of…
Knowledge for Growth 2023
Knowledge for Growth, Europe’s leading conference in the field of life sciences, is set to take place in Antwerp, Belgium on June 1, 2023. This exceptional event will bring together…
Ronald van der Geest shares his experience as a speaker
Fast-track drug development: taking the highway or the roundabout? In a race against time, costs and competitors, the pharmaceutical industry finds itself at a crossroads. As the world demands faster…
3D-PharmXchange and CR2O are celebrating and securing the successful ongoing collaboration
A successful drug development strategy is a well-designed and dynamic process. Making sure regulatory requirements are embedded from the start, is key. From pre-clinical all the way to registration, a…
2023 Conferences & Events
3D-PharmXchange will be attending, exhibiting and/or presenting at the following conferences and events in 2023: Click on the event name for more information. Event Date(s) Location Exhibitor/Attendee World ADC March…
Leadership At Treeway
In 2013, Inez de Greef – van der Sandt was appointed as CEO for our client Treeway, a biotechnology company with a mission to develop therapies to cure ALS. Treeway…
Drug Development Strategy: The Treeway Story
The valley of death is often mentioned when talking about drug development. It’s the place where most biotech companies do not survive. Not Treeway, a small Dutch biotech company that…